Brand names
Amphetamine and Dextroamphetamine brand names
6 brands in 1 markets
Amphetamine and Dextroamphetamine is sold under 6 brand names in 1 markets in our register data, including Adderall, Adderall XR, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII, Mixed Salts of a Single Entity Amphetamine Product XR, Mixed Salts of a Single-Entity Amphetamine Product, Mydayis. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Adderall | United States | Teva Pharmaceuticals | 1.25 mg/1.25 mg/1.25 mg/1.25 mg, 1.875 mg/1.875 mg/1.875 mg/1.875 mg, 2.5 mg/2.5 mg/2.5 mg/2.5 mg, 3.125 mg/3.125 mg/3.125 mg/3.125 mg, 3.75 mg/3.75 mg/3.75 mg/3.75 mg, 5 mg/5 mg/5 mg/5 mgTablet | US FDA NDC directoryChecked 12 November 2026 |
| Adderall XR | United States | Takeda Pharmaceuticals | 1.25 mg/1.25 mg/1.25 mg/1.25 mg, 2.5 mg/2.5 mg/2.5 mg/2.5 mg, 3.75 mg/3.75 mg/3.75 mg/3.75 mg, 5 mg/5 mg/5 mg/5 mg, 6.25 mg/6.25 mg/6.25 mg/6.25 mg, 7.5 mg/7.5 mg/7.5 mg/7.5 mgExtended-release capsule | US FDA NDC directoryChecked 12 November 2026 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII | United States | Alvogen | 1.25 mg/1.25 mg/1.25 mg/1.25 mg, 2.5 mg/2.5 mg/2.5 mg/2.5 mg, 3.75 mg/3.75 mg/3.75 mg/3.75 mg, 5 mg/5 mg/5 mg/5 mg, 7.5 mg/7.5 mg/7.5 mg/7.5 mgTablet | US FDA NDC directoryChecked 12 November 2026 |
| Mixed Salts of a Single Entity Amphetamine Product XR | United States | SpecGx | 1.25 mg/1.25 mg/1.25 mg/1.25 mg, 2.5 mg/2.5 mg/2.5 mg/2.5 mg, 3.75 mg/3.75 mg/3.75 mg/3.75 mg, 5 mg/5 mg/5 mg/5 mg, 6.25 mg/6.25 mg/6.25 mg/6.25 mg, 7.5 mg/7.5 mg/7.5 mg/7.5 mgExtended-release capsule | US FDA NDC directoryChecked 12 November 2026 |
| Mixed Salts of a Single-Entity Amphetamine Product | United States | SpecGx | 12.5 mg/12.5 mg/12.5 mg/12.5 mg, 3.125 mg/3.125 mg/3.125 mg/3.125 mg, 6.25 mg/6.25 mg/6.25 mg/6.25 mg, 9.375 mg/9.375 mg/9.375 mg/9.375 mgExtended-release capsule | US FDA NDC directoryChecked 12 November 2026 |
| Mydayis | United States | Takeda Pharmaceuticals | 12.5 mg/12.5 mg/12.5 mg/12.5 mg, 3.125 mg/3.125 mg/3.125 mg/3.125 mg, 6.25 mg/6.25 mg/6.25 mg/6.25 mg, 9.375 mg/9.375 mg/9.375 mg/9.375 mgExtended-release capsule | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Amphetamine and Dextroamphetamine for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.